Human Leukocyte Antigens: An Update on Structure, Function and Nomenclature

References

• Leukocyte Typing I, A Bernard, L Boumsell, J Dausset, C Milstein, S F Schlossman. Springer-Verlag, Berlin 1984
   Google Scholar
• Leukocyte Typing II, E L Reinherz, B F Haynes, L M Nadler, I D Bernstein. Springer-Verlag, Berlin 1985
   Google Scholar
• Leukocyte Typing III, A McMichael. Oxford University Press, in the Press, Oxford
   Google Scholar
• Brockhaus M. Detection of glycolipid antigens with monoclonal antibodies. Immunological Methods. Academic press, New York 1985; Vol III
   Google Scholar
• Freedman A S, Boyd A W, Anderson K C, et al. B5, a new B cell-specific activation antigen. J Immunol 1985; 134: 2048–53
   Google Scholar
• Burns G F, Triglia T, Werkmeister J A, et al. TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J Exp Med 1985; 161: 1063–78
   PubMed Web of Science ®Google Scholar
• Foon K A, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 13
   Google Scholar
• Moriomoto C, Letvin N C, Boyd A W, et al. The isolation and characterization of the helper inducer T cell subset. J Immunol 1985; 134: 3762–69
   Google Scholar
• Nadler LM. B cell leukemia panel workshop: summary and comments. Leukocyte Typing II, E Reinherz, B Haynes, L Nadler, I Bernstein. Springer Verlag, Berlin 1985; Vol. II: 33
   Google Scholar
• Nadler L M, Korsmeyer S J, Anderson K L, et al. The B cell origin of non-T cell acute lymphoblastic leukaemia: A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984; 74: 332–43
   PubMed Web of Science ®Google Scholar
• Boyd A W, Anderson K C, Freedman A S, et al. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. J Immunol 1985; 134: 1516–23
   PubMed Web of Science ®Google Scholar
• Hast T, Dowding C, Robak T, Goldman JM. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies. Exp Hematol 1986; 14: 981–7
   Google Scholar
• Calabi F, Milstein C. A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature 1986; 323: 540–3
   PubMed Web of Science ®Google Scholar
• Thomas M L, Barclay A N, Gagnon J, Williams AF. Evidence from cDNA clones that the rat leukocyte common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr Cell. 1985; 41: 83–93
   Google Scholar
• Shackleford D A, Trowbridge IS. Identification of lymphocyte integral membrane proteins as substrates for Protein Kinase C. J Biol Chem 1986; 261: 8334–41
   Google Scholar
• Boyd A W, Fisher D C, Schlossman S F, Nadler LM. Structural and functional characterization of IL-2 receptors on activated human B cells. J Immunol 1985; 134: 2356–61
   Google Scholar
• Hermann F, Cannistra S A, Levine H, Griffin JD. Expression of interleukin 2 receptors and binding of IL-2 by γ-interferon induced human leukemic and normal monocytic cells. J Exp Med 1985; 162: 1111–6
   PubMed Web of Science ®Google Scholar
• Leonard W J, Depper J M, Crabtree G R, et al. Molecular cloning and expression of cDNA's for the human interleukin-2 receptor. Nature 1984; 311: 626–31
   PubMed Web of Science ®Google Scholar
• Tsudo M, Kozak R W, Goldman C K, Waldmann TA. Demonstration of a non-Tac peptide that bind IL-2: A potential participant in a multi chain interleukin-2 receptor complex. Proc Natl Acad Sci 1986; 83: 9694–8
   PubMed Web of Science ®Google Scholar
• Waldmann T A, Longo D L, Leonard W J, et al. Interleukin-2 receptor (Tac antigen) expression in HTLV-I-associated adult T cell leukemia. Cancer Res 1985; 45: 4559, s-62S
   PubMed Web of Science ®Google Scholar
• Strom T B, Barnett L V, Ganiton G N, et al. Prolongation of cardiac allograft survival in rodent recipients treated with an anti-interleukin-2 receptor monoclonal antibody. Clin Res 1985; 33: 561a
   Google Scholar
• Maddon P J, Dalgleish A G, McDougal J S, et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47: 333–48
   PubMed Web of Science ®Google Scholar
• Maddon P J, Littman D R, Godfrey M, et al. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 1985; 42: 93–104
   PubMed Web of Science ®Google Scholar
• Littman D R, Thomas Y, Maddon P J, et al. Isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell 1985; 40: 237–46
   PubMed Web of Science ®Google Scholar
• Sukhatine V P, Sicer K D, Vollner A C, et al. The T cell differentiation antigen Leul/T8 is homologous to immunoglobulin and T cell receptor variable regions. Cell 1985; 40: 591–7
   Google Scholar
• Sanchez-Madrid F, Nagy J, Robbins E, et al. A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit. J Exp Med 1983; 158: 1785–94
   PubMed Web of Science ®Google Scholar
• Yamada H, Martin P J, Bean M A, et al. Monoclonal antibody 9.3 and anti-CD11 antibodies define recirprocal subsets of lymphocytes. Eur J Immunol 1985; 15: 1164–68
   Google Scholar
• Anderson K C, Boyd A W, Leslie D, et al. Hairy cell leukemia: A tumor of pre-secretory B cells. Blood 1985; 64: 620–8
   Google Scholar
• Tamkun K W, de Simone D W, Fonda D, et al. Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 1986; 47: 271–82
   Google Scholar
• Springer T A, Thompson W S, Miller L J, et al. Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoproteins family and its molecular basis. J Exp Med 1984; 160: 1901–23
   PubMed Web of Science ®Google Scholar
• Clark E A, Ledbetter JA. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp 35 and Bp 50. Proc Natl Acad Sci 1986; 83: 4494–8
   PubMed Web of Science ®Google Scholar
• Tedder T F, Boyd A W, Freedman A S, et al. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol 1985; 135: 973–9
   PubMed Web of Science ®Google Scholar
• Nadler L M, Takvorian T, Botnick L, et al. Anti-B1 monoclonal antibody and complement treatment in autologous bone marrow transplantation for relapsed B cell non-Hodgkins lymphoma. Lancet 1984; 2: 427–31
   PubMed Web of Science ®Google Scholar
• Gordon J, Rowe M, Walker L, Guy G. Ligation of CD23, p45 (BLAST-2, EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Eur J lmmunol 1986; 15: 1075–80
   Google Scholar
• Antin J H, Emerson S G, Martin P, et al. Leu-1 + (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol 1986; 136: 505–10
   PubMed Web of Science ®Google Scholar
• Plater-Zybark C, Lam Maini S N, et al. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthritis Rheum. 1985; 28: 971–6
   Google Scholar
• Braun J, Citri Y, Baltimore D, et al. B-Lyl cells: Immortal Ly-1 positive B lymphocyte cell lines spontaneously arising in murine splenic cultures. Immunol Rev 1986; 93: 5–21
   Google Scholar
• Huang L C, Civin C I, Magem J L, et al. My-1, the human myeloid specific antigen detected by mouse monoclonal antibodies is a sugar sequence found in lacto-N-fucopentose III. Blood 1983; 61: 1020–8
   PubMed Web of Science ®Google Scholar
• Hsu S-M, Ho Y-S, Li P-J, et al. L & H variants of Reed-Sternberg cells express sialated LeuMl antigen. Am J Pathol 1986; 122: 199–203
   PubMed Web of Science ®Google Scholar
• Griffin J D, Linch D C, Sabbath K, et al. A monoclonal antibody reactive with normal and leukaemic human myeloid progenitor cells. Leukaemia Res. 1984; 8: 521–34
   PubMed Web of Science ®Google Scholar
• Civin C I, Strauss L C, Brosall C, et al. Antigenic analysis of hemopoiesis. III. A hemopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KGI cells. J Immunol, 133: 157–63
   Google Scholar
• Burns G F, Begley C G, Mackay I R, et al. “Supernatural” killer cells. Immunology Today 1985; 6: 370–3
   PubMedGoogle Scholar
• Fischer A, Griscelli C, Blanche S, et al. Prevention of graft failure by an anti-MLFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation. Lancet 1986; 2: 1058–61
   PubMed Web of Science ®Google Scholar
• Filipovitch A H, Vallera D A, Youle R J, et al. Ex vivo treatment of donor bone marrow with anti-T-cell immunotoxins and prevention of graft-versus-host disease. Lancet 1984; 2: 469–71
   Google Scholar
• Browman G P, Necune P B, Soamboonsrup P. The contribution of cytochemistry and immunophenotyping of the reproducibility of the FAB classification of acute leukemia. Blood 1986; 68: 900–5
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M-T, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage. Ann Intern Med 1985; 103: 460–2
   PubMed Web of Science ®Google Scholar
• Lanier L L, Phillips JH. Evidence for three types of human cytotoxic lymphocyte. Immunology Today 1986; 7: 132–4
   PubMedGoogle Scholar
• Grimm EA. Human lymphokine activated killer cells (LAK cells) as a potential therapeutic modality. Biochem Biophys Acta 1986; 855: 267–79
   Google Scholar